CaMKIIα hub ligands are unable to reverse known phenotypes in Angelman syndrome mice.
Gauger SJ, Lie MEK, Wallaard I, Tian Y, Marek A, Frølund B, van Woerden GM, Elgersma Y, Kornum BR, Wellendorph P.
Gauger SJ, et al. Among authors: van woerden gm.
Basic Clin Pharmacol Toxicol. 2025 Jan;136(1):e14112. doi: 10.1111/bcpt.14112.
Basic Clin Pharmacol Toxicol. 2025.
PMID: 39668309